Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 64 | BES2019 | Next issue

Belgian Endocrine Society 2019

BES 2019

Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor

ea0064032 | Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor | BES2019

Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor

Haemels M , Delaunoit T , Van Laere K , Van Cutsem E , Verslype C , Bex M , Deroose CM

A 57 years-old patient presented with back pain, general discomfort, polydipsia, polyuria, fatigue and recent weight loss of 10 kg. Biochemical evaluation showed hypercalcemia (2.85 mmol/l; normal: 2.15–2.55) with low PTH level (14,2 ng/L; normal 14.9–56.9 ng/l) excluding primary hyperparathyroidism. The most frequent cause of hypercalcemia with non-elevated PTH levels is an underlying malignancy1. CT-thorax-abdomen showed a pancreatic neuroendocrine tumor...